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ABSTRACT The structure and membrane interaction of the antimicrobial peptide aurein 2.2 (GLFDIVKKVVGALGSL-CONH2),
aurein 2.3 (GLFDIVKKVVGAIGSL-CONH2), both from Litoria aurea, and a carboxy C-terminal analog of aurein 2.3
(GLFDIVKKVVGAIGSL-COOH) were studied to determine which features of this class of peptides are key to activity. Circular
dichroism and solution-state NMR data indicate that all three peptides adopt an a-helical structure in the presence of triﬂuoro-
ethanol or lipids such as 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) and a 1:1 mixture of DMPC and 1,2-dimyristoyl-sn-
glycero-3-[phospho-rac-(1-glycerol)] (DMPG). Oriented circular dichroism was used to determine the orientation of the peptides in
lipid bilayers over a range of concentrations (peptide/lipid molar ratios (P/L)¼ 1:15–1:120) in DMPC and 1:1 DMPC/DMPG, in the
liquid crystalline state. The results demonstrate that in DMPC all three peptides are surface adsorbed over a range of low peptide
concentrations but insert into the bilayers at high peptide concentrations. This ﬁnding is corroborated by 31P-solid-state NMR data
of the three peptides in DMPC, which shows that at high peptide concentrations the peptides perturb the membrane. Oriented
circular dichroism data of the aurein peptides in 1:1 DMPC/DMPG, on the other hand, show that the peptides with amidated
C-termini readily insert into the membrane bilayers over the concentration range studied (P/L ¼ 1:15–1:120), whereas the aurein
2.3 peptide with a carboxy C-terminus inserts at a threshold concentration of P/L* between 1:80 and 1:120. Overall, the data
presented here suggest that all three peptides studied interact with phosphatidylcholinemembranes in amanner which is similar to
aurein 1.2 and citropin 1.1, as reported in the literature, with no correlation to the reported activity. On the other hand, both aurein
2.2 and aurein 2.3 behave similarly in phosphatidylcholine/phosphatidylglycerol (PC/PG)membranes, whereas aurein 2.3-COOH
inserts less readily. As this does not correlate with reported activities, minimal inhibitory concentrations of the three peptides
against Staphylococcus aureus (strain C622, ATCC 25923) and Staphylococcus epidermidis (strain C621—clinical isolate) were
determined. The correlation between structure, membrane interaction, and activity are discussed in light of these results.
INTRODUCTION
Cationic antimicrobial peptides are an important class of
peptides which target a wide range of microbes, such as bac-
teria and fungi, and disease-causing agents, such as cancer
cells and viruses (1,2). They are ubiquitous in the animal and
plant kingdoms and constitute an important part of the
immune defense system. To date, they have displayed little
or no resistance effects (3–5), making them prime targets for
development as a new class of antiinfective agents. The
thousand peptides identiﬁed to date share a common three-
dimensional arrangement in the presence of membranes, de-
spite the diversity in the amino acid sequences and structures
(e.g., b-sheets, a-helices, loops, and extended structures)
they adopt (1). They form amphiphilic molecules, where one
face of the peptide is hydrophobic and the other is positively
charged (3), thereby allowing them to interact and bind with
the negatively charged bacterial membranes. A model which
can be used to account for the initial interactions of most an-
timicrobial peptides with membranes is the Shai-Matsuzaki-
Huang model (6–10). Brieﬂy, this model proposes that the
peptides are initially unstructured in solution and fold in the
presence of membranes or membrane mimetics. The peptides
then integrate into the outer half of the membrane, leading to
thinning of the outer leaﬂet (11–13). This is followed by
membrane disruption via a barrel-stave model, carpet model,
toroidal pore model, micellar aggregate channel model (14,15),
or detergent-like mechanism (16). Finally, the bacterial cells
are killed via, for example, membrane depolarization, deg-
radation of cell walls, and micellization, to name a few mech-
anisms (17).
An important family of cationic antimicrobial peptides is
those secreted by amphibians. When these animals are ex-
posed to a variety of stimuli, host-defense compounds, con-
sisting of amines, alkaloids, and peptides, are secreted (18).
A great many studies have been performed on peptides
obtained from amphibians and have been reviewed exten-
sively in the literature (for recent reviews, see Zasloff (2),
Pukala et al. (18), and Rinaldi (19)). Examples of a few am-
phibian host-defense peptides include magainins (9,20–28),
maculatins (29–34), and brevinins (35–40). Another example
is the family of aurein peptides from the Australian southern
bell frogs Litoria aurea and Litoria raniformis (18,32,33,41),
which is the focus of this contribution.
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Aurein peptides display a wide range of sequence diversity
and activity with respect to Gram-positive bacteria (Bacillus
cereus, Leuconostoc lactis, Listeria innocua, Micrococcus
luteus, Staphylococcus aureus, and Staphylococcus epider-
midis) and cancers (41). By far the most studied member of
this family is aurein 1.2 (30,31,33,42,43). It is a 13-residue
peptide with a net positive charge of 11. It possesses an
amidated C-terminus (CONH2 group) which increases the
positive charge of the peptide, which in turn is deemed
essential for its antibacterial action (18,32). It is most active
against L. lactis (with a minimal inhibitory concentration
(MIC) of 12 mg.mL1), followed by S. aureus, S.
epidermidis, and Streptococcus uberis (with MICs of 50
mg.mL1) (41,44). Solution-state NMR and circular dichro-
ism (CD) studies have shown that it adopts an a-helical
conformation in membrane mimetic environments: 70%
triﬂuoroethanol (TFE)/30% water (41) and sodium dodecyl
sulfate micelles (45). Since, the length of aurein 1.2 is too
short (;19.5 A˚ (29)) to span ﬂuid lipid bilayers (;40 A˚), it
is proposed that this peptide interacts primarily with the
membrane interface and promotes bilayer damage by a
detergent-like or carpet-like mechanism. Another wide-
spectrum antibiotic which behaves in exactly the same
manner is citropin 1.1, a 16-residue peptide with a net 12
charge (18,32,33).
In this contribution, we report data on two 16-residue
peptides from the aurein family: aurein 2.2 (net charge 12)
and aurein 2.3 (net charge12). Aurein 2.2 (Aur2.2-CONH2)
is active against a number of Gram-positive bacteria. For
example, it displays a MIC of 25 mg.mL1 for S. aureus and
S. epidermidis (41), i.e., it is more active than aurein 1.2 in
this case and equally active to citropin 1.1. Aurein 2.3 (Aur2.3-
CONH2), on the other hand, is generally only marginally
active, with typical MICs of 100 mg.mL1 (41). The dif-
ference in amino acid sequence between aurein 2.2 and 2.3 is
only a conservative mutation of a leucine to an isoleucine at
position 13. To assess how this mutation may be correlated
to activity, we have determined the structure of Aur2.2-
CONH2 and Aur2.3-CONH2 in TFE, in 1,2-dimyristoyl-sn-
glycero-3-phosphocholine (DMPC) small unilamellar vesicles
(SUVs), and in 1:1 DMPC/1,2-dimyristoyl-sn-glycero-3-
[phospho-rac-(1-glycerol)] (DMPG) SUVs, using CD. The
structures of the peptides in 25% TFE were also determined
using solution-state 1H-NMR. To further determine how
activity is modulated by sequence, we have also studied
a modiﬁed version of aurein 2.3 in which the amidated
C-terminus is replaced by a carboxyl group (Aur2.3-COOH).
In addition, we have determined the interaction of these three
peptides with model zwitterionic (DMPC) membranes, using
oriented CD and 31P-solid-state NMR, to determine how
they perturb the membrane bilayer. We have also determined
how these peptides interact with bacterial model membranes
consisting of a 1:1 mixture of DMPC/DMPG using oriented
circular dichroism (OCD). Finally, we have tested the anti-
biotic activity of the three peptides against S. Aureus (strain
C622, ATCC 25923) and S. epidermidis (strain C621—
clinical isolate). Overall, these data should enable us to corre-
late structure and membrane interaction of these three mar-
ginally different peptides with antibiotic activity and lead to
a better understanding of how sequence modulates function
in the aurein peptide family.
MATERIALS AND METHODS
Materials
Fmoc-protected amino acids, Wang and Rink resin, and 2-(1H-benzotriazol-1-
yl)-1,1,3,3-tetramethyluronium hexaﬂuorophosphate (HBTU) were purchased
from Advanced Chem Tech (Louisville, KY). N-Hydroxybenzotiazhole
(HOBt) was obtained from Novabiochem (San Diego, CA). N,N-Dimethyl-
formamide (DMF), dichloromethane (DCM), acetonitrile (AcN), and po-
tassium nitrate were purchased from Fisher Chemicals (Nepean, Ontario,
Canada). N,N-Diiopropylethylamine (DIEA), triﬂuoroacetic acid (TFA),
ethane dithiol (EDT), and triethylsilane (TES) were obtained from Sigma-
Aldrich (St. Louis, MO). Mylar plates were made by cutting Melinex
Teijin ﬁlms from Dupont (Wilton, UK). DMPC and DMPG were pur-
chased from Avanti Polar Lipids (Alabaster, AL) and obtained dissolved in
chloroform.
Methods
Peptide synthesis
Aurein 2.2 and aurein 2.3 (Aur2.3-CONH2) were synthesized using Rink
resin. Aur2.3-COOH was synthesized using Wang resin. In all cases, the
synthesis was started by ﬁrst precoupling the ﬁrst residue (Fmoc-Leu) to the
appropriate resin. Brieﬂy, 0.30 mmol of the resin was presoaked for;1 h in
10 mL DMF. Then Fmoc-Leu was preactivated by dissolving in 0.5 M DMF
with 1 mmol HBTU, 1 mmol HOBT, and 2 mmol DIEA. The Fmoc-Leu was
then added to the resin. The mixture was spun overnight.
Next, the peptides were synthesized using an Applied Biosystems 431A
peptide synthesizer (Foster City, CA) by the in situ neutralization Fmoc
chemistry, using the preloaded Leu-Wang resin or Leu-Rink resin, as appro-
priate. Side chains were protected as follows: Asp(OtBu), Lys(Boc), and
Ser(tBu). For double coupling of serine, leucine, and isoleucine, one extra
step of coupling was performed for each amino acid with only DMF washes
in between. After chain assembly was completed, the peptide was deprotected
and cleaved simultaneously from the resin using a cleavage mixture of 81%
TFA, 5% ddH2O, 2.5% EDT, and 1% TES for 5 h. TFA was then removed
from the mixture by rotary evaporation. Chilled diethyl ether was used to
precipitate the crude product. Finally, the resulting peptide was dissolved in
water and lyophilized.
Puriﬁcation
The crude peptide product was puriﬁed by preparative reverse-phase-high-
performance liquid chromatography on aWaters 600 system (Waters Limited,
Mississauga, Ontario, Canada) with 229-nm ultraviolet detection, using a
Phenomenex (Torrance, CA) C4 preparative column (20 mm, 2.1 3 25 cm)
at a ﬂow rate of 20 mL/min and linear gradient of 0–50% buffer B (10%
ddH2O, 90% AcN containing 0.1% TFA) in buffer A (90% ddH2O, 10%
AcN containing 0.1% TFA) over 80 min. The identity of the products was
veriﬁed using spectrometry: Aur2.2-CONH2, purity $99%, molecular
weight (MW)¼ 1615.0 (from matrix-assisted laser desorption ionization-time
of ﬂight (MALDI-TOF)); Aur2.3-CONH2, purity $99%, MW ¼ 1615.0
(from MALDI-TOF); Aur2.3-COOH, purity $98%, MW ¼ 1616.0 (from
MALDI-TOF).
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Solution CD sample preparation
Solution CD samples with a constant peptide concentration of 200 mMwere
prepared in different compositions of water and TFE: 100% water, 75%
water with 25% TFE, 50% water with 50% TFE, and 25% water with 75%
TFE. Different peptide/DMPC and peptide/DMPC/DMPG lipid molar ratios
of samples were also prepared: 1:15, 1:50, and 1:100. Appropriate amounts
of lipids in chloroform were vacuum dried in a 25-mL round bottom ﬂask
overnight followed by addition of peptide in water. The mixture was soni-
cated in a water bath for at least 30 min (i.e., until the solution was no longer
turbid) to ensure lipid vesicle formation. For all samples, corresponding
background samples without peptides were prepared for spectral subtraction.
Solution NMR sample preparation
The peptides were dissolved in 65% water, 25% d3-TFE, and 10% D2O.
Each peptide sample had a ﬁnal concentration of 2 mM, with a total volume
of 600 mL.
Mechanically oriented sample preparation
For solid-state NMR analysis, samples were prepared for four different
peptide/DMPC lipid molar ratios of 1:15, 1:30, 1:40, and 1:120. The amount
of DMPC (dissolved in chloroform) was kept constant at 19.18 mmol. The
lipid was dried using a stream of air to remove most of the chloroform. Then,
the appropriate amount of peptide was added and the mixture was re-
dissolved in 800 mL of methanol. The mixture was deposited in 5-mL por-
tions repeatedly onto nine Mylar plates, which were placed in a petri dish.
Between depositions, most of the methanol evaporated before the next
portion was deposited onto the plate. The plated samples were then covered
and left to dry overnight on the bench. The slides, on which the samples were
still slightly humid (;1 ml of water per slide), were stacked. Next, the
samples were placed in a 93% relative humidity chamber and were indirectly
hydrated by incubating inside the desiccator at 37C for 4 days. The humid-
ity of the samples was veriﬁed by visual inspection. The degree of alignment
was veriﬁed by 31P-solid-state NMR. Consistent sample preparation was
veriﬁed by preparing 2–3 samples for each lipid composition and peptide
concentration. Finally, the plated samples were wrapped in a thin layer of
paraﬁlm before data acquisition.
For oriented CD analysis, samples were prepared in a similar fashion as
described above. The peptide amount was kept constant at 0.5 mmol and
mixed with appropriate molar ratios of DMPC or DMPC/DMPG and
sonicated in 2 mL of methanol. Each mixture was deposited in 90-mL
portions with a syringe onto 3 3 1 cm and 1-mm-thick quartz slides, which
were cleaned thoroughly with ethanol. After indirect hydration of the
samples, clear layers of samples were obtained on the slides. Each sample
was covered with a second slide with a spacer in between. Spacers were
made by cutting six layers of stacked paraﬁlm into a rectangular 3 3 1 cm
frame with 2-mm width. To hold the slides in place, a thin layer of paraﬁlm
was wrapped around the edges of the slides.
Circular dichroism
CD experiments were carried out using a JASCO J-810 spectropolarimeter
(Victoria, British Columbia, Canada) at 30C. The spectra were obtained
over a wavelength range of 185–250 nm. Continuous scanning mode with a
response of 1 s with 0.5-nm steps, bandwidth of 1.5 nm, and a scan speed of
20 nm/min were used. The signal/noise ratio was increased by acquiring
each spectrum over an average of three scans. Finally, each spectrum was
corrected by subtracting the background from the sample spectrum. Solution
CD samples were placed in a cell (0.1 cm in length) in 200-mL portions,
whereas oriented CD samples on quartz slides were directly placed in the
sample compartment. The temperature was kept constant by means of a
water bath.
NMR spectroscopy
Solution-state NMR data were acquired on a Bruker 500-MHz instrument
(Milton, Ontario, Canada), operating at a 1H frequency of 500.17 MHz. The
parameters for the experiments were chosen to match previously reported
parameters for aurein 1.2 (43) as much as possible. All spectra were col-
lected at 25C. Spectra were acquired using total correlation spectroscopy
(TOCSY) and nuclear Overhauser enhancement spectroscopy (NOESY)
experiments in phase-sensitive mode using time proportional phase incremen-
tation (TPPI) (46) in the indirect dimension. The TOCSY experiment used
the MLEV17 sequence for mixing (mixing time ¼ 70 ms) and excitation
sculpting with gradients for water suppression (47). The two-dimensional
data set consisted of 4096 data points in t2 and 256 points in t1. The NOESY
experiment was acquired with a mixing time of 150 ms and also used
excitation sculpting for water suppression. The data size for this data set was
the same as for the TOCSY spectrum. Signals were averaged using 32 scans
for the TOCSY and 64 scans for the NOESY experiments, respectively. The
spectra were referenced to the residual methylene protons present in d3-TFE
(3.918 ppm). Spectra were processed to result in 1k 3 1k points.
31P-solid-state NMR experiments on mechanically aligned DMPC sam-
ples were carried out on the same Bruker 500-MHz NMR spectrometer, op-
erating at a phosphorus frequency of 202.48 MHz. 31P-NMR spectra were
obtained at 30C with a single 31P-pulse/1H-decoupling sequence where the
decoupling was achieved using SPINAL-16 (48). The 90 pulse was set to
9.75 ms and a 3-s recycle delay was used. Each spectrum was acquired using
2048 scans, with no line broadening applied.
Minimal inhibitory concentration determination
MIC for Aur2.2-CONH2, Aur2.3-CONH2, and Aur2.3-COOH were deter-
mined based on the previously described modiﬁed methodology (49).
Brieﬂy, 18-h cultures of S. aureus C622 (ATCC 25923) and S. epidermidis
C621 (clinical isolate generously donated by D. Speert) grown in Mueller
Hinton (MH) medium (Difco, Oakville, Ontario, Canada) were diluted to
;2 3 105 colony forming units per mL. Then 90 mL of diluted culture was
dispensed into a 96-well polystyrene microtitre plate (Costar, Cambridge,
MA). Separately, twofold serial dilutions in sterile MH broth of the
respective peptide were carried out at 103 ﬁnal concentration before 10 mL
of each dilution was transferred to the culture and grown for 18 h at 37C
before being read. The MIC was recorded as the lowest concentration of
peptide in which no visible growth could be observed. Controls included the
peptide antibiotic polymyxin B (Sigma, St. Louis, MO). In addition, culture-
only and broth-only wells were used.
RESULTS
Structure determination of aurein peptides by CD
and solution-state NMR
To determine which structure the Aur2.2-CONH2, Aur2.3-
CONH2, and Aur2.3-COOH peptides adopt in water and in
the presence of model membranes, solution CD experiments
were performed. Fig. 1 shows that all three peptides adopt a
random coil conformation in aqueous solution (Fig. 1, a–c,
solid black line). Upon addition of TFE, all three peptides
change conformation. Spectra consisting of a peak at 190 nm
and two minima at 210 nm and 222 nm, which are char-
acteristic of a-helical structure, are observed for all TFE
concentrations (25%, 50%, and 75%) and all peptides. As
TFE has been shown to promote the formation of a-helices
(for a recent example, see Perham et al. (50)), CD spectra
of the Aur2.2-CONH2, Aur2.3-CONH2, and Aur2.3-COOH
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peptides were also determined in DMPC and DMPC/DMPG
(1:1) SUVs to determine the true conformation in a mem-
brane environment. The spectra, illustrated in Figs. 2, a–c,
and 3, a–c, respectively, demonstrate that the aurein peptides
also adopt an a-helical conformation in this case. Similar
intensities were observed for all the peptide/lipid molar ratios
(P/L ¼ 1:15, 1:50, and 1:100) studied here. This indicates
that maximum binding of the peptide to the vesicles oc-
curred. Evidence for saturation would manifest itself in a
change in the CD signal, due to the contribution to the signal
from an increased proportion of random coil structure (33).
To determine whether the peptides adopt a continuous
a-helical structure or whether the peptides are bent, 1H-solution-
state NMR experiments were performed. As no changes in
the CD spectra were observed in the TFE concentration range
used here, the solution-state NMR spectra were collected
using 25% d3-TFE. The
1H-NMR spectra for the three
peptides were assigned using the TOCSY and NOESY data
sets, using TOPSPIN. Of all three peptides, the spectra for
Aur2.3-CONH2 were the least overlapped. The assignments
(not shown) did not vary signiﬁcantly from peptide to peptide,
giving us a ﬁrst indication that the peptides all adopt similar
structures. In the HN-HN region (not shown) and in the ﬁn-
gerprint region (Fig. 4, a–c), a large number of sequential (i to
i 1 1) connectivities were observed. At a low contour level,
additional i to i 1 2 connectivities were observed in the
FIGURE 1 Solution CD spectra of the aurein peptides in water/TFE
mixtures: (a) Aur2.2-CONH2, (b) Aur2.3-CONH2, and (c) Aur2.3-COOH
(solid black line, 100% H2O; black dotted line, 75% H2O/25% TFE; solid
gray line, 50% H2O/50% TFE; gray dotted line, 25% H2O/75% TFE). The
spectra indicate that, in all cases, the peptides are unstructured in water but
adopt an a-helical conformation upon addition of TFE.
FIGURE 2 Solution CD spectra of the aurein peptides in DMPC SUVs:
(a) Aur2.2-CONH2, (b) Aur2.3-CONH2, and (c) Aur2.3-COOH (solid black
line, P/L ¼ 1:15; dotted line, P/L ¼ 1:50; solid gray line, P/L ¼ 1:100). The
spectra indicate that the peptides adopt an a-helical conformation in the
presence of DMPC SUVs.
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HN-HN region, as summarized in Fig. 5 b for Aur2.3-CONH2.
Other nuclear Overhauser enhancement (NOE) connectivities
observed include daN(i,i1 4), daN(i,i1 3), and dab(i,i1 3),
as summarized in Fig. 5 b. These data as well as the observed
chemical shift differences of the measured Ha chemical
shifts with respect to random coil values (51) (Fig. 5 a)
suggest that all three peptides adopt a continuous a-helical
structure. Full structure calculations (not performed at this
time) could be used to further conﬁrm these results.
Membrane interaction of aurein peptides by
oriented CD and 31P-solid-state NMR
To determine how the Aur2.2-CONH2, Aur2.3-CONH2, and
Aur2.3-COOH peptides interact with membrane bilayers,
OCD and 31P-solid-state NMR experiments were carried out.
For both methods, samples were prepared in almost identical
fashion so that the data sets could be compared directly and
also to verify that the samples were aligned. All experiments
were conducted at 30C, i.e., in the liquid crystalline phase
for DMPC/DMPG. In addition, experiments were repeated
at least twice, using at least two different samples (for each
concentration), to ensure reproducibility of the results. The
OCD results for the Aur2.2-CONH2, Aur2.3-CONH2, and
Aur2.3-COOH peptides in DMPC and DMPC/DMPG (1:1)
bilayers are shown in Fig. 6. The spectra were scaled so that
the minimum at 222 nm has the same intensity. The data
illustrate that at a peptide/lipid (P/L) molar ratio of 1:15, all
peptides are no longer completely in the surface-adsorbed
or S state (52,53) in DMPC (Fig. 6, a–c). In fact, at this P/L
ratio, the peptides can be seen as either i), being in the
inserted or I state with a tilt angle (33,54)—also known as the
tilted or T-state (55); or ii), being 50% oriented transmem-
brane and 50% surface adsorbed (53). As the peptide is too
short to span the membrane bilayer entirely, since its hydro-
phobic length is ;24 A˚ and the DMPC bilayer hydrophobic
thickness is 26.5 A˚ (12,56) in the liquid crystalline phase, it
is quite likely that the peptide is inserted at an angle at P/L¼
1:15. The critical threshold peptide concentration (P/L*) is
between 1:15 and 1:30 for the amidated peptides, whereas it
is between 1:30 and 1:40 for Aur2.3-COOH. These threshold
concentrations are similar to those observed for aurein 1.2
and citropin 1.1 (33), where a change is observed to occur
between P/L molar ratios of 1:50 and 1:15. Interestingly, the
Aur2.3-COOH peptide, which is presumably the least active
of the three peptides, appears to insert into phosphatidyl-
choline (PC) bilayers slightly more readily than its amidated
C-terminus counterpart. In DMPC/DMPG bilayers (Fig. 6,
d–f ), the amidated peptides insert at all concentration ranges
shown, i.e., for P/L ratios of 1:120–1:15. Indeed, even at
very low peptide concentrations (P/L ; 1:200), Aur2.2-
CONH2 and Aur2.3-CONH2 remain in the I-state (data not
shown). For the Aur2.3-COOH peptide, on the other hand,
the threshold P/L* concentration is between 1:80 and 1:120,
indicating that comparatively high peptide concentrations are
needed for insertion to take place. This is most likely due to
the unfavorable electrostatic interactions between the neg-
atively charged C-terminus and the negatively charged PG
headgroups (57).
31P-NMR spectra (shown in Fig. 7) were recorded for all
peptides in DMPC. The spectra, acquired with the membrane
normal parallel to the magnetic ﬁeld, illustrate that for the
most part, the lipids remain aligned with increasing peptide
concentration. The peptides appear to disorder the headgroups
somewhat, as evidenced by the scaling of the 31P-chemical-
shielding anisotropy. In addition, the peptides affect the
dynamics of the lipid headgroups, as shown by a decrease in
T2, leading to line broadening. Both these effects have also
been previously observed for aurein 1.2 and citropin 1.1
(31). In addition, a small proportion of the lipid headgroups
FIGURE 3 Solution CD spectra of the aurein peptides in DMPC/DMPG
(1:1) SUVs: (a) Aur2.2-CONH2, (b) Aur2.3-CONH2, and (c) Aur2.3-COOH
(solid black line, P/L ¼ 1:15; dotted line, P/L ¼ 1:50; solid gray line, P/L ¼
1:100). The spectra indicate that the peptides adopt an a-helical conforma-
tion in the presence of DMPC/DMPG SUVs.
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are signiﬁcantly perturbed, as seen by the appearance of an
additional 31P-NMR resonance (at 12 ppm) with increasing
peptide concentration. The presence of a peak near the
isotropic position has previously been observed in 31P-NMR
spectra of aurein 1.2 and has been attributed to membrane
disruption (31). Generally, the presence of a peak at or near
the isotropic position has been observed in solid-state NMR
studies of other antimicrobial peptides (26,58–60) and has
been attributed to the formation of small lipid vesicles/
micelles, the formation of a different lipid phase (26), or
toroidal pore defects within the bilayer (59,61). To clearly
identify which of these mechanisms is relevant here, addi-
tional data from experiments such as differential scanning
calorimetry (to determine changes in phase) or 15N-NMR (to
determine the orientation of the peptide in the bilayer) would
be needed. As the aim of this study was to determine whether
the aurein peptides studied here behave differently to aurein
1.2 and citropin 1.1 (which promote bilayer damage via a de-
tergent-like mechanism (16), resulting in turn in membrane
leakage (30)) and to determine whether this can be correlated
to activity, the exact nature of the manner in which Aur2.2-
CONH2, Aur2.3-CONH2, and Aur2.3-COOH perturb DMPC
membranes will not be characterized further at this point in
time. The 31P-NMR data suggest in corroboration with the
OCD results that the interaction of these three peptides with
DMPC bilayers is identical.
Antibiotic activity of the aurein peptides
Given that all three peptides studied here adopt a-helical
structure regardless of membrane environment (DMPC
versus DMPC/DMPG) and given that the peptides interact
with the membranes in a manner which cannot be directly
correlated to activity, MICs of all three peptides against two
Gram-positive bacteria (S. aureus and S. epidermidis) were
determined. The MICs, reported in Table 1, indicate that the
amidated peptides have very similar activities under condi-
tions used here, contrary to what is reported in the literature
FIGURE 4 Fingerprint region of solution NMR NOESY spectra of (a) Aur2.2-CONH2, (b) Aur2.3-CONH2, and (c) Aur2.3-COOH. The spectra were
acquired using a phase-sensitive NOESY experiment, with excitation sculpting with gradients for water suppression (see text). All spectra were acquired at
25C, using 64 scans and a mixing time of 150 ms. The spectra were referenced to the residual methylene protons present in d3-TFE (3.918 ppm). In b, arrows
indicate some of the connectivities use to perform the sequential assignment. In ambiguous cases, the HN-HN region was also used to conﬁrm i to i 1 1
connectivities.
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(41). Aur2.2-CONH2 and Aur2.3-CONH2 have similar
MICs of 15 mg.mL1 and 25 mg.mL1, respectively, against
the wild-type S. aureus strain C622. Likewise, these two
peptides have identical MICs of 8 mg.mL1 against S.
epidermidis strain C621. The COOH version of aurein 2.3,
on the other hand, is not active with MICs of.100 mg.mL1
for both types of bacteria. Peptides with charged C-termini
have been found to be inactive or much less active (18,41)
than their amidated counterparts. Wells containing poly-
myxin B, culture only, and broth only were used as controls.
The MICs observed for polymyxin B are reported in Table
1 and agree with literature ﬁndings (62).
DISCUSSION
Determining the structure of antimicrobial peptides and
characterizing their interaction with lipid bilayers is essential
to understanding how they function and kill bacteria. By
elucidating the mode of action of antibiotics, it is possible to,
on the one hand, better understand how microbes develop
resistance (5), and on the other, develop modiﬁed versions of
these agents to mitigate this development. An approach
which has received much attention recently is to search for
naturally occurring antibiotic molecules derived from the
plant and animal kingdoms (1,3,15,16,63), which have net
positive charge and typically adopt amphiphilic structures to
maximize their interactions with bacterial membranes.
To elucidate the mode of action of a cationic antimicrobial
peptide, one typically picks a highly active peptide and deter-
mines i), its structure by CD and/or NMR in a membrane or
membrane mimetic environment, and ii), its interaction with
model membrane bilayers such as 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (POPC) (e.g., MSI-78 and MSI-
594 (64)), DPhPC (e.g., alamethicin (61,65)), DMPC (e.g.,
aurein 1.2 (33)), and other diacylphosphatidylcholine mem-
branes (e.g., K2(LA)xK2 (66)), i.e., lipids which are good
models for probing the hemolytic activity of the peptides, or
lipid mixtures, such as POPC/PG (e.g., MSI-78 and MSI-594
(64)) and DMPC/DMPG (e.g., PGLa (55)), i.e., bacterial
model membranes. To completely describe the peptide-lipid
interactions, one needs to take into account a range of param-
eters such as peptide/lipid ratio, membrane composition,
FIGURE 5 NMR-derived evidence
indicating that the aurein peptides are
a-helical: (a) Ha chemical shift differ-
ences for Aur2.2-CONH2 (hashed),
Aur2.3-CONH2 (solid black), and
Aur2.3-COOH (open); (b) typical
NOE connectivities observed for these
peptides—shown here for Aur2.3-
CONH2 only. Solid black bars repre-
sent unambiguous NOEs, and gray bars
represent connectivities which are pre-
sent but are ambiguous due to overlap.
2860 Pan et al.
Biophysical Journal 92(8) 2854–2864
temperature, hydration, buffer composition (16), and lipid
phase (61). Once this is taken into consideration, one typi-
cally generates a model by which the peptide inserts into the
lipid bilayer: via the carpet mechanism (6), barrel-stave (10)
or toroidal (67) pore formation, or simply a detergent-like
mechanism (16,23), as previously mentioned.
Here we have taken a slightly different approach in that we
have studied three peptides which have essentially the same
amino acid sequence but have very different reported ac-
tivities (41) with respect to different microbes. Aurein 2.2
(GLFDIVKKVVGALGSL-CONH2) is reported to be the
most active of the three peptides investigated. It shares its
ﬁrst 9 residues in common with citropin 1.1 (though 2 resi-
dues have slightly different order), which is also 16 amino
acid residues in length. Presumably this sequence similarity
may explain why Aur2.2-CONH2 and citropin 1.1 display
similar activities against L. lactis, S. aureus, and S. epidermidis
(43). Aurein 2.3, on the other hand, with a single point mu-
tation L-13/I-13, is only marginally active (41). We also
investigated a modiﬁed version of aurein 2.3, with a carboxy
C-terminus. Since most active members of the aurein peptide
family have an amidated C-terminus, with only one aurein
(aurein 5.2) with a COOH terminus being active, and then
only marginally so (43), it is expected that Aur2.3-COOH
will at best be only marginally active.
The data presented here show that despite the difference in
sequence and in reported activity, all three peptides adopt
continuous a-helical structures. The results from solution
FIGURE 6 Oriented CD spectra for
(a) Aur2.2-CONH2, (b) Aur2.3-CONH2,
and (c) Aur2.3-COOH in DMPC and (a)
Aur2.2-CONH2, (b) Aur2.3-CONH2,
and (c) Aur2.3-COOH in DMPC/
DMPG (1:1). P/L molar ratios ¼ 1:15
(blue), 1:30 (green), 1:40 (red), 1:80
(black), and 1:120 (gray). The spectra
were normalized such that the intensities
of all spectra at 222 nm are the same. The
spectra show that the peptides insert into
the DMPC bilayer at threshold P/L*
molar ratios between 1:15 and 1:30 for
Aur2.2-CONH2 and Aur2.3-CONH2,
and 1:30 and 1:40 for Aur2.3-COOH.
In DMPC/DMPG (1:1), the amidated
peptides are inserted over the entire
concentration range, whereas the P/L*
is between 1:120 and 1:80 for Aur2.3-
COOH under these conditions.
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CD and NMR are, in fact, analogous to those reported in the
literature for aurein 1.2 and citropin 1.1 (33,43). In all cases,
these antimicrobial peptides are unstructured in solution and
then fold in the presence of membranes or membrane mi-
metics. In other words, all peptides follow the ﬁrst step of the
Shai-Matsuzaki-Huang model (6–10) regardless of whether
the peptides are in TFE, DMPC SUVs, or DMPC/DPMG
(1:1) SUVs. Once folded, the aurein peptides studied here
then interact with PC membranes by predominantly associ-
ating with the surface. At high concentrations, the peptides
realign from a surface-bound S-state to a tilted T-state (i.e.,
insert at a tilt angle). The exact value of this tilt angle has yet
to be determined (e.g., by labeling one residue with 15N
(31,33)) but is expected to be similar to that of citropin 1.1
(33), given the same length of the peptides. The transition
from the S to the T state occurs at P/L* between 1:15 and
1:30 for the amidated peptides and between 1:30 and 1:40 for
Aur2.3-COOH. The slightly more favorable insertion of
Aur2.3-COOH into PC membranes is most likely due to elec-
trostatic interactions (57). Repulsive interactions between
C-termini which are in proximity when the peptide is surface
associated are presumably minimized when the peptides
insert. The 31P-NMR spectra of aligned peptides in DMPC
show that at high peptide concentrations, a proportion of the
lipid headgroups are perturbed. This is again similar to what
was observed for aurein 1.2 and citropin 1.1 (31). The similar
OCD and NMR spectra observed for all peptides suggest that
the interaction of the aurein peptides with PC membranes
does not depend on sequence or the nature of the C-terminus.
The interactions of the aurein peptides with bacterial model
membranes consisting of DMPC/DMPG (1:1), on the other
hand, show that the nature of the C-terminus modulates
peptide insertion. Aur2.2-CONH2 and Aur2.3-CONH2 dis-
play similar behavior and insert readily into PC/PG mem-
branes, even at low peptide concentrations (i.e., P/L* ,
1:200). The Aur2.3-COOH peptide inserts into PC/PG
membranes at P/L* between 1:120 and 1:80. In other words,
it inserts more readily into PC/PG membranes than in PC
alone but does not insert as easily as the amidated peptides
do. Clearly, the charge interactions between the positively
charged Lys side chains and the negatively charged lipid
headgroups drive all the aurein peptides to interact with and
insert more readily in PC/PG bilayers. The charge repulsions
between the COOH terminus and the PG headgroups result
in higher Aur2.3-COOH peptide concentration needed for
the T state to be achieved.
Overall, the structural and membrane interaction data
indicate that the single point mutation L-13/I-13 in going
from Aur2.2-CONH2 to Aur2.3-CONH2 does not affect how
these peptides fold and interact with DMPC and DMPC/
DMPG membranes. This is consistent with the new activity
measurements reported here, which show that these two
peptides have similar bactericidal properties. This indicates
that small changes in the overall hydrophobicity of a peptide
(i.e., leucine and isoleucine have slightly different hydro-
phobicity scales (68)) are not likely to have an effect on the
activity of a cationic antimicrobial peptide. In addition, the
data indicate that the nature of the C-terminus, speciﬁcally its
charge, does not affect the structure a cationic antimicrobial
FIGURE 7 31P-solid-state NMR spectra of all three aurein peptides
oriented in DMPC bilayers. The spectra were recorded using 2048 scans at
30C, oriented such that the membrane normal was parallel to the external
magnetic ﬁeld. The spectra were processed without any line broadening (see
text for further experimental details).
TABLE 1 MICs in mg.mL1 of Aur2.2-CONH2, Aur2.3-CONH2,
Aur2.3-COOH, and polymyxin B (control) toward S. aureus and
S. epidermidis (see text for experimental details)
Peptide
S. aureus
strain C622
S. aureus
(41)
S. epidermidis
strain C621
S. epidermidis
(41)
Aur2.2-CONH2 15 25 8 25
Aur2.3-CONH2 25 100 8 100
Aur2.3-COOH $100 – .128 –
Polymyxin B 50 – 55 –
MICs are given as the most frequently observed value obtained from repeat
experiments.
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peptide adopts in the presence of membrane but rather its
interaction with charged lipid headgroups. The MICs ob-
tained for the Aur2.3-COOH peptide clearly show that a
charged C-terminus can destroy the antibiotic activity.
In conclusion, we have demonstrated that to elucidate the
mode of action of a family of cationic antimicrobial peptides,
it may be useful to compare peptides with similar sequences
but different activities to determine whether structure and/or
membrane interactions are important for activity. We have
also shown that it is important to study these peptides in
bacterial model membranes (DMPC/DMPG) and not DMPC
alone, as electrostatic interactions are an important driving
force for peptide-lipid interactions. Finally, now that we have
determined under which conditions the Aur2.2-CONH2 and
Aur2.3-CONH2 peptides perturb lipid bilayers and how that
is correlated with activity, we will determine the exact
mechanism by which these peptides bring about membrane
disruption. We will verify whether the detergent-like mech-
anism proposed for aurein 1.2 and citropin 1.1 based on data
obtained in DMPC (31,33) is also relevant for the aurein 2.2
and 2.3 peptides studied here.
The CD/OCD measurements were performed at the University of British
Columbia Centre for Biological Calorimetry (CBC).
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